Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Ceftazidime pentahydrate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ceftazidime 1g powder for solution for injection vials
0501021H0AAABAB
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | 15 |
|
Ceftazidime 2g powder for solution for injection vials
0501021H0AAACAC
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | 11 |
|
Ceftazidime 3g powder for solution for injection vials
0501021H0AAAHAH
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | 1 |
|
Ceftazidime 250mg powder for solution for injection vials
0501021H0AAADAD
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | No data available |
|
Ceftazidime 500mg powder for solution for injection vials
0501021H0AAAAAA
|
Ceftazidime pentahydrate | Ceftazidime pentahydrate | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.